Persistent Asset Partners’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$79.8K Buy
+28,801
New +$116K 0.02% 340

Other funds holding ZNTL

Persistent Asset Partners's ZNTL Position: Q3 2026 in Review

Persistent Asset Partners opened a new position in Zentalis Pharmaceuticals (ZNTL) in Q3 2026: 28,801 shares worth $79.8K. The stake represents 0.02% of the portfolio and ranks #340 among its holdings.

128 funds tracked by Wall St. Rank hold ZNTL as of Q3 2026.

  • Persistent Asset Partners held 28,801 shares of Zentalis Pharmaceuticals worth $79.8K as of Q3 2026.
  • Zentalis Pharmaceuticals was a new Persistent Asset Partners position in Q3 2026.
  • Zentalis Pharmaceuticals made up 0.02% of Persistent Asset Partners's portfolio in Q3 2026, its #340 holding.
  • 128 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q3 2026.

Based on Persistent Asset Partners's 13F filing for Q3 2026, filed 13 Nov 2026.